China SXT Pharmaceuticals (SXTC) Short Interest Ratio & Short Volume $1.20 -0.36 (-23.08%) Closing price 05/16/2025 04:00 PM EasternExtended Trading$1.88 +0.68 (+56.25%) As of 05/16/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock China SXT Pharmaceuticals Short Interest DataChina SXT Pharmaceuticals (SXTC) has a short interest of 51,300 shares, representing 0.37% of the float (the number of shares available for trading by the public). This marks a -2.66% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1.09 million shares to cover all short positions.Current Short Interest51,300 sharesPrevious Short Interest52,700 sharesChange Vs. Previous Month-2.66%Dollar Volume Sold Short$87,210.00Short Interest Ratio0.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares723,000 sharesFloat Size13,730,000 sharesShort Percent of Float0.37%Today's Trading Volume4,363,404 sharesAverage Trading Volume1,094,839 sharesToday's Volume Vs. Average399% Short Selling China SXT Pharmaceuticals? Sign up to receive the latest short interest report for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSXTC Short Interest Over TimeSXTC Days to Cover Over TimeSXTC Percentage of Float Shorted Over Time China SXT Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202551,300 shares $87,210.00 -2.7%0.4%0 $1.70 3/31/202552,700 shares $133,067.50 +60.2%0.4%0.6 $2.53 3/15/202532,900 shares $92,778.00 -54.8%0.2%0.3 $2.82 2/28/202572,800 shares $328,328.00 +1,448.9%3.2%0.4 $4.51 2/15/20254,700 shares $14,363.20 -95.0%0.1%0 $3.06 1/31/202594,100 shares $38,581.00 +129.0%2.7%0.1 $0.41 1/15/202541,100 shares $16,135.86 -89.1%1.2%0 $0.39 12/31/2024377,600 shares $191,858.56 +44.1%11.0%0.4 $0.51 12/15/2024262,000 shares $100,870.00 +263.4%7.6%0.3 $0.39 11/30/202472,100 shares $28,840.00 +7.6%2.1%0.1 $0.40 Get the Latest News and Ratings for SXTC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for China SXT Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/15/202467,000 shares $25,935.03 -36.4%2.0%0.1 $0.39 10/31/2024105,300 shares $58,862.70 -46.3%3.1%0.2 $0.56 10/15/2024196,000 shares $123,970.00 -22.1%5.7%0.3 $0.63 9/30/2024251,600 shares $183,617.68 -44.7%7.3%0.3 $0.73 9/15/2024455,300 shares $303,229.80 +744.7%13.1%0.7 $0.67 8/31/202453,900 shares $33,886.93 +32.8%1.6%0.1 $0.63 8/15/202440,600 shares $41,818.00 -23.3%1.2%0.1 $1.03 7/31/202452,900 shares $58,719.00 -68.2%7.6%0.1 $1.11 7/15/2024166,100 shares $195,998.00 +347.7%24.0%0.3 $1.18 6/30/202437,100 shares $40,439.00 -25.1%5.4%0 $1.09 6/15/202449,500 shares $54,450.00 +43.1%9.3%0 $1.10 5/31/202434,600 shares $36,343.84 +76.5%6.5%0 $1.05 5/15/202419,600 shares $21,364.00 +36.1%3.6%0 $1.09 4/30/202414,400 shares $15,264.00 -77.4%2.6%0 $1.06 4/15/202463,600 shares $74,412.00 +142.8%11.6%0.1 $1.17 3/31/202426,200 shares $44,016.00 +376.4%4.8%0 $1.68 3/15/20245,500 shares $9,570.00 -93.4%1.0%0 $1.74 2/29/202482,800 shares $163,116.00 +145.0%15.1%0.1 $1.97 2/15/202433,800 shares $73,684.00 -59.3%6.2%0 $2.18 1/31/202483,000 shares $161,020.00 +538.5%14.8%0.1 $1.94 1/15/202413,000 shares $24,440.00 +100.0%2.3%0 $1.88 12/31/20236,500 shares $25,805.00 -67.3%1.2%0 $3.97 12/15/202319,900 shares $38,805.00 -33.7%3.6%0.1 $1.95 11/30/202330,000 shares $63,600.00 +67.6%5.3%0.2 $2.12 11/15/202317,900 shares $42,602.00 -70.2%3.2%0.1 $2.38 10/31/202360,100 shares $129,221.01 -21.4%10.7%0.3 $2.15 10/15/202376,500 shares $225,675.00 +948.0%13.6%0.3 $2.95 9/30/20237,300 shares $22,447.50 -98.7%0.1%0 $3.08 9/15/2023575,400 shares $75,780.18 +99.7%4.6%0.1 $0.13 8/31/2023288,100 shares $32,555.30 +553.3%2.4%0.1 $0.11Shocking AI play that’s beats Nvidia by a country mile (Ad)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is about to announce could change the AI market once again. Experts already predict the total addressable market could climb past $20 trillion. But Sykes believes most investors have missed what’s coming next. He’s tracking a new shift — and says the biggest gains are still ahead.Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 8/15/202344,100 shares $6,513.57 -61.1%0.4%0 $0.15 7/31/2023113,300 shares $23,113.20 +18.1%1.0%0.2 $0.20 7/15/202395,900 shares $18,796.40 -8.2%1.1%0.1 $0.20 6/30/2023104,500 shares $24,557.50 +5.9%1.2%0.1 $0.24 6/15/202398,700 shares $23,737.35 +4.0%1.2%0.1 $0.24 5/31/202394,900 shares $19,255.21 -69.1%1.1%0.2 $0.20 5/15/2023307,300 shares $69,019.27 +1,034.0%3.6%0.5 $0.22 4/30/202327,100 shares $6,720.80 +942.3%0.3%0 $0.25 4/15/20232,600 shares $621.14 -83.5%0.1%0 $0.24 3/31/202315,800 shares $4,480.88 +13.7%0.5%0 $0.28 3/15/202313,900 shares $4,075.48 -68.3%0.5%0 $0.29 2/28/202343,800 shares $17,182.74 -25.5%1.4%0.1 $0.39 2/15/202358,800 shares $28,812.00 -18.0%1.8%0.1 $0.49 1/31/202371,700 shares $40,144.83 -10.7%2.3%0.1 $0.56 1/15/202380,300 shares $47,377.00 -22.8%1.7%0.1 $0.59 12/30/2022104,000 shares $56,368.00 -68.0%2.2%0.2 $0.54 12/15/2022324,500 shares $195,803.30 +587.5%7.6%0.6 $0.60 11/30/202247,200 shares $33,035.28 +193.2%2.2%0.1 $0.70 11/15/202216,100 shares $10,787.00 -17.0%0.7%0 $0.67 10/31/202219,400 shares $11,640.00 -62.4%0.9%0 $0.60 10/15/202251,600 shares $35,088.00 -16.9%2.4%0.1 $0.68 9/30/202262,100 shares $47,817.00 -50.2%2.8%0.1 $0.77 9/15/2022124,600 shares $139,552.00 -11.3%5.7%0.3 $1.12 8/31/2022140,400 shares $197,262.00 +345.7%6.4%0.3 $1.41 8/15/202231,500 shares $51,345.00 +34.6%1.3%0.2 $1.63 7/31/202223,400 shares $34,164.00 -67.1%1.0%0.2 $1.46 7/15/202271,100 shares $129,402.00 +17.5%4.1%0.7 $1.82 6/30/202260,500 shares $105,875.00 -38.3%3.5%0.6 $1.75 6/15/202298,100 shares $162,846.00 +42.4%5.6%0.3 $1.66 5/31/202268,900 shares $144,690.00 +98.0%4.0%0.2 $2.10 5/15/202234,800 shares $115,118.40 -95.9%2.0%0.1 $3.31 4/30/2022856,400 shares $183,440.88 +7.5%N/A0.1 $0.21 4/15/2022796,400 shares $175,208.00 -84.4%N/A0.1 $0.22 3/31/20225,100,000 shares $1.43 million +1,933.5%38.7%0.5 $0.28 3/15/2022250,800 shares $42,134.40 +19.0%1.9%0 $0.17 2/28/2022210,800 shares $45,954.40 -56.7%1.6%0 $0.22 2/15/2022487,200 shares $89,157.60 -34.7%3.7%0.2 $0.18 1/31/2022746,200 shares $160,656.86 +294.6%5.7%0.3 $0.22 1/15/2022189,100 shares $101,735.80 -32.3%1.4%0.1 $0.54 12/31/2021279,200 shares $181,563.76 +50.6%2.3%0.5 $0.65 12/15/2021185,400 shares $119,564.46 -47.3%1.5%0.4 $0.64 11/30/2021351,800 shares $248,529.46 -31.1%2.9%0.7 $0.71 11/15/2021510,500 shares $433,925.00 -16.6%4.1%1.1 $0.85 10/29/2021612,000 shares $581,767.20 +107.0%5.0%1.3 $0.95 10/15/2021295,600 shares $275,114.92 -18.4%2.4%0.6 $0.93 9/30/2021362,300 shares $373,169.00 -24.4%2.9%0.2 $1.03 9/15/2021479,400 shares $498,576.00 -10.0%3.9%0.2 $1.04 8/31/2021532,900 shares $623,493.00 -3.0%4.3%0.2 $1.17 8/13/2021549,200 shares $648,056.00 -18.8%4.4%0.2 $1.18 7/30/2021675,900 shares $844,875.00 +38.9%5.1%0.3 $1.25Think NVDA’s run was epic? You ain’t seen nothin’ yet (Ad)Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 7/15/2021486,600 shares $729,900.00 -19.5%3.6%0.2 $1.50 6/30/2021604,700 shares $876,815.00 +19.2%4.5%2.5 $1.45 6/15/2021507,300 shares $715,293.00 -5.0%3.8%1.4 $1.41 5/28/2021533,900 shares $688,731.00 -3.2%4.0%0.9 $1.29 5/14/2021551,400 shares $634,110.00 +2.9%4.1%0.8 $1.15 4/30/2021536,100 shares $771,984.00 -19.7%4.0%0.5 $1.44 4/15/2021667,500 shares $987,900.00 +25.5%5.0%0.4 $1.48 3/31/2021531,700 shares $988,962.00 +21.1%4.0%0.2 $1.86 3/15/2021438,900 shares $877,800.00 +34.1%3.3%0.2 $2.00 2/26/2021327,300 shares $680,784.00 -77.3%2.4%0.1 $2.08 2/12/20211,440,000 shares $1.48 million +15.2%N/A0.6 $1.03 1/29/20211,250,000 shares $841,750.00 +15.7%N/A0.2 $0.67 1/15/20211,080,000 shares $683,532.00 +38.2%N/A0.2 $0.63 12/31/2020781,700 shares $269,686.50 +334.5%N/A0.2 $0.35 12/15/2020179,900 shares $55,265.28 +32.4%N/A0.1 $0.31 11/30/2020135,900 shares $40,076.91 +27.5%N/A0 $0.29 11/15/2020106,600 shares $27,982.50 -78.7%N/A0.1 $0.26 10/30/2020500,400 shares $146,367.00 +220.8%N/A0.2 $0.29 10/15/2020156,000 shares $42,057.60 +24.2%N/A0.1 $0.27 9/30/2020125,600 shares $30,746.88 -81.3%N/A0 $0.24 9/15/2020671,200 shares $171,558.72 +377.7%N/A0.2 $0.26 8/31/2020140,500 shares $42,178.10 -60.4%N/A0 $0.30 8/14/2020354,600 shares $131,131.08 +158.8%N/A0.1 $0.37 7/31/2020137,000 shares $54,334.20 +2.2%N/A0 $0.40 7/15/2020134,000 shares $58,263.20 -84.3%1.0%0 $0.43 6/30/2020853,600 shares $469,053.20 +723.9%6.3%0.1 $0.55 6/15/2020103,600 shares $46,640.72 -53.8%0.8%0 $0.45 5/29/2020224,200 shares $88,693.52 -73.5%1.7%0.1 $0.40 SXTC Short Interest - Frequently Asked Questions What is China SXT Pharmaceuticals' current short interest? Short interest is the volume of China SXT Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 51,300 shares of SXTC short. 0.37% of China SXT Pharmaceuticals' shares are currently sold short. Learn More on China SXT Pharmaceuticals' current short interest. What is a good short interest percentage for China SXT Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.37% of China SXT Pharmaceuticals' floating shares are currently sold short. Is China SXT Pharmaceuticals' short interest increasing or decreasing? China SXT Pharmaceuticals saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 51,300 shares, a decrease of 2.7% from the previous total of 52,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is China SXT Pharmaceuticals' float size? China SXT Pharmaceuticals currently has issued a total of 723,000 shares. Some of China SXT Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. China SXT Pharmaceuticals currently has a public float of 13,730,000 shares. How does China SXT Pharmaceuticals' short interest compare to its competitors? 0.37% of China SXT Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to China SXT Pharmaceuticals: NLS Pharmaceutics Ltd. (5.82%), Mainz Biomed (5.38%), GT Biopharma, Inc. (1.74%), HCW Biologics Inc. (1.03%), Jaguar Health, Inc. (20.36%), 180 Life Sciences Corp. (21.45%), Apollomics, Inc. (1.17%), Ensysce Biosciences, Inc. (12.01%), Sonoma Pharmaceuticals, Inc. (3.31%), Aptorum Group Limited (2.10%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short China SXT Pharmaceuticals stock? Short selling SXTC is an investing strategy that aims to generate trading profit from China SXT Pharmaceuticals as its price is falling. SXTC shares are trading down $0.36 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against China SXT Pharmaceuticals? A short squeeze for China SXT Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SXTC, which in turn drives the price of the stock up even further. How often is China SXT Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SXTC, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies NLS Pharmaceutics Short Interest Mainz Biomed Short Interest GT Biopharma Short Interest HCW Biologics Short Interest Jaguar Health Short Interest 180 Life Sciences Short Interest Apollomics Short Interest Ensysce Biosciences Short Interest Sonoma Pharmaceuticals Short Interest Aptorum Group Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SXTC) was last updated on 5/18/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowMusk has launched a bold new AI initiative—and while you can’t invest in it directly, one overlooked stock cou...Behind the Markets | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Two drop-dead simple ways to play the gold boomIf you take a few minutes to check out the short research briefing Mark & I have put together, I’m confident y...Eagle Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China SXT Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China SXT Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SXTC Stock Free SXTC Stock Alerts